Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 5.69% | 14.98% | 24.65% | 46.54% | 13.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.69% | 14.98% | 24.65% | 46.54% | 13.16% |
| Cost of Revenue | -18.75% | -7.58% | 38.34% | 61.05% | 48.71% |
| Gross Profit | 13.34% | 23.12% | 21.34% | 41.84% | 5.28% |
| SG&A Expenses | 16.48% | 35.71% | 40.51% | 30.76% | 10.03% |
| Depreciation & Amortization | 50.61% | -11.61% | 11.24% | 10.21% | -21.68% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.63% | 23.19% | 38.40% | 37.75% | 13.01% |
| Operating Income | -37.09% | -60.66% | -118.42% | -22.22% | -12.25% |
| Income Before Tax | 13.04% | -47.18% | -145.27% | 12.47% | -145.72% |
| Income Tax Expenses | -- | -- | -- | -1,077.32% | -- |
| Earnings from Continuing Operations | 13.04% | -47.18% | -142.78% | 34.22% | -145.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.04% | -47.18% | -142.78% | 34.22% | -145.72% |
| EBIT | -37.09% | -60.66% | -118.42% | -22.22% | -12.25% |
| EBITDA | -29.82% | -92.83% | -165.99% | -23.01% | -26.28% |
| EPS Basic | 14.69% | -43.38% | -136.23% | 35.57% | -142.47% |
| Normalized Basic EPS | -23.68% | -106.78% | -139.53% | -33.87% | -72.73% |
| EPS Diluted | 14.69% | -30.00% | -120.27% | 35.57% | -136.00% |
| Normalized Diluted EPS | -19.44% | -114.04% | -116.28% | -33.87% | -63.64% |
| Average Basic Shares Outstanding | 1.88% | 2.79% | 3.31% | 2.11% | 2.07% |
| Average Diluted Shares Outstanding | 7.39% | -1.08% | 13.98% | 2.11% | 6.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
